UTHR

UNITED THERAPEUTICS Corp

SEC CIK 1082554
$536.59 +13.4% · 90 days
90-day buys
$0
0 open-market
90-day sells
$272.52M
521 open-market
Net insider flow
−$272.52M
Net selling
Filings shown
726
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at UTHR have sold a net $272.52M of stock (0 open-market buys vs 521 sells).

Largest recent trade: Mahon Paul A sold $2.88M of UTHR, trimming their stake 17%.

Most active filer: Rothblatt Martine A, with 428 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for UTHR, newest first
View on SEC EDGAR ↗
UTHR
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed 2w ago ΔOwn −3.1%

Mahon Paul A sold $812.2K of UTHR, trimming their stake 3%.

−$812.2K
1,481 sh @ $548
UTHR
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed 2w ago ΔOwn −1.3%

Mahon Paul A sold $325.9K of UTHR, trimming their stake 1%.

−$325.9K
593 sh @ $549
UTHR
Sell MAHON PAUL A · EVP & GENERAL COUNSEL · Open-market sale · filed 2w ago ΔOwn −2.7%

Mahon Paul A sold $686.8K of UTHR, trimming their stake 3%.

−$686.8K
1,250 sh @ $549
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −0.8%

Rothblatt Martine A sold $218.1K of UTHR, trimming their stake 1%.

−$218.1K
401 sh @ $544
Advertisement
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −2.3%

Rothblatt Martine A sold $621K of UTHR, trimming their stake 2%.

−$621K
1,139 sh @ $545
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −2.2%

Rothblatt Martine A sold $573.3K of UTHR, trimming their stake 2%.

−$573.3K
1,050 sh @ $546
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −3.5%

Rothblatt Martine A sold $910.1K of UTHR, trimming their stake 4%.

−$910.1K
1,664 sh @ $547
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −4.9%

Rothblatt Martine A sold $1.22M of UTHR, trimming their stake 5%.

−$1.22M
2,226 sh @ $548
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −4.5%

Rothblatt Martine A sold $1.07M of UTHR, trimming their stake 4%.

−$1.07M
1,956 sh @ $549
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −2.0%

Rothblatt Martine A sold $463.2K of UTHR, trimming their stake 2%.

−$463.2K
842 sh @ $550
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −2.3%

Rothblatt Martine A sold $621.4K of UTHR, trimming their stake 2%.

−$621.4K
1,160 sh @ $536
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −4.2%

Rothblatt Martine A sold $1.1M of UTHR, trimming their stake 4%.

−$1.1M
2,056 sh @ $537
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −3.1%

Rothblatt Martine A sold $787.1K of UTHR, trimming their stake 3%.

−$787.1K
1,464 sh @ $538
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −2.5%

Rothblatt Martine A sold $619.1K of UTHR, trimming their stake 3%.

−$619.1K
1,149 sh @ $539
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −5.2%

Rothblatt Martine A sold $1.25M of UTHR, trimming their stake 5%.

−$1.25M
2,310 sh @ $540
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −1.5%

Rothblatt Martine A sold $346.5K of UTHR, trimming their stake 2%.

−$346.5K
641 sh @ $540
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −1.1%

Rothblatt Martine A sold $238.3K of UTHR, trimming their stake 1%.

−$238.3K
440 sh @ $542
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −0.7%

Rothblatt Martine A sold $152.1K of UTHR, trimming their stake 1%.

−$152.1K
280 sh @ $543
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −2.7%

Rothblatt Martine A sold $744K of UTHR, trimming their stake 3%.

−$744K
1,365 sh @ $545
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −4.5%

Rothblatt Martine A sold $1.21M of UTHR, trimming their stake 5%.

−$1.21M
2,213 sh @ $546
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −3.0%

Rothblatt Martine A sold $752.8K of UTHR, trimming their stake 3%.

−$752.8K
1,376 sh @ $547
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −3.4%

Rothblatt Martine A sold $847.5K of UTHR, trimming their stake 3%.

−$847.5K
1,546 sh @ $548
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −2.7%

Rothblatt Martine A sold $640.5K of UTHR, trimming their stake 3%.

−$640.5K
1,166 sh @ $549
UTHR
Sell ROTHBLATT MARTINE A · Director, Chairperson & CEO · Open-market sale · filed 2w ago ΔOwn −2.5%

Rothblatt Martine A sold $588.8K of UTHR, trimming their stake 3%.

−$588.8K
1,070 sh @ $550
Advertisement

About UTHR insider activity

This page tracks every recent Form 4 filed for UNITED THERAPEUTICS Corp with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is UTHR insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for UNITED THERAPEUTICS Corp usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.